Loading clinical trials...
Loading clinical trials...
The Role of Glucagon-like Peptide-1 Receptor Signalling in the Glucose-lowering Effect of Increased Carbohydrate Content in the Distal Small Intestines After Meal Ingestion in Patients With Type 2 Diabetes
Conditions
Interventions
Acarbose
Placebo Oral Tablet
+2 more
Locations
1
Denmark
Center for Diabetesresearch
Hellerup, Denmark
Start Date
August 1, 2017
Primary Completion Date
January 1, 2018
Completion Date
January 1, 2018
Last Updated
March 26, 2020
NCT02710370
NCT06619834
NCT07288372
NCT06668090
NCT01028846
NCT04791787
Lead Sponsor
University Hospital, Gentofte, Copenhagen
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions